Quantitative signal detection using spontaneous ADR reporting
Quantitative methods are increasingly used to analyse spontaneous reports. We describe
the core concepts behind the most common methods, the proportional reporting ratio (PRR) …
the core concepts behind the most common methods, the proportional reporting ratio (PRR) …
Novel statistical tools for monitoring the safety of marketed drugs
JS Almenoff, EN Pattishall, TG Gibbs… - Clinical …, 2007 - Wiley Online Library
Robust tools for monitoring the safety of marketed therapeutic products are of paramount
importance to public health. In recent years, innovative statistical approaches have been …
importance to public health. In recent years, innovative statistical approaches have been …
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases the notoriety bias
A Pariente, F Gregoire, A Fourrier-Reglat, F Haramburu… - Drug safety, 2007 - Springer
Background: Disproportionality analysis of spontaneous reporting is increasingly used, but it
may be influenced in unknown ways by safety alerts (notoriety bias). Objective: To explore …
may be influenced in unknown ways by safety alerts (notoriety bias). Objective: To explore …
Comparison of statistical signal detection methods within and across spontaneous reporting databases
G Candore, K Juhlin, K Manlik, B Thakrar, N Quarcoo… - Drug safety, 2015 - Springer
Background Most pharmacovigilance departments maintain a system to identify adverse
drug reactions (ADRs) through analysis of spontaneous reports. The signal detection …
drug reactions (ADRs) through analysis of spontaneous reports. The signal detection …
Considerations on the use of different comparators in pharmacovigilance: A methodological review
CA Gravel, A Douros - British journal of clinical pharmacology, 2023 - Wiley Online Library
Pharmacovigilance studies based on spontaneous reporting systems use disproportionality
analysis methods to identify drug‐event combinations with higher‐than‐expected reporting …
analysis methods to identify drug‐event combinations with higher‐than‐expected reporting …
Decision support methods for the detection of adverse events in post-marketing data
M Hauben, A Bate - Drug discovery today, 2009 - Elsevier
Spontaneous reporting is a crucial component of post-marketing drug safety surveillance
despite its significant limitations. The size and complexity of some spontaneous reporting …
despite its significant limitations. The size and complexity of some spontaneous reporting …
Nanomedicinal products: a survey on specific toxicity and side effects
W Brand, CW Noorlander, C Giannakou… - International journal …, 2017 - Taylor & Francis
Due to their specific properties and pharmacokinetics, nanomedicinal products (NMPs) may
present different toxicity and side effects compared to non-nanoformulated, conventional …
present different toxicity and side effects compared to non-nanoformulated, conventional …
[HTML][HTML] Signal detection in pharmacovigilance: a review of informatics-driven approaches for the discovery of drug-drug interaction signals in different data sources
The objective of this article is to review the application of informatics-driven approaches in
the pharmacovigilance field with focus on drug-drug interaction (DDI) safety signal discovery …
the pharmacovigilance field with focus on drug-drug interaction (DDI) safety signal discovery …
Mining unexpected temporal associations: applications in detecting adverse drug reactions
H Jin, J Chen, H He, GJ Williams… - IEEE Transactions …, 2008 - ieeexplore.ieee.org
In various real-world applications, it is very useful mining unanticipated episodes where
certain event patterns unexpectedly lead to outcomes, eg, taking two medicines together …
certain event patterns unexpectedly lead to outcomes, eg, taking two medicines together …
Mining patients' narratives in social media for pharmacovigilance: adverse effects and misuse of methylphenidate
X Chen, C Faviez, S Schuck, A Lillo-Le-Louët… - Frontiers in …, 2018 - frontiersin.org
Background: The Food and Drug Administration (FDA) in the United States and the
European Medicines Agency (EMA) have recognized social media as a new data source to …
European Medicines Agency (EMA) have recognized social media as a new data source to …